chr17-31318443-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014210.4(EVI2A):c.571G>A(p.Ala191Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014210.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EVI2A | NM_014210.4 | c.571G>A | p.Ala191Thr | missense_variant | 2/2 | ENST00000462804.3 | |
NF1 | NM_001042492.3 | c.4836-7377C>T | intron_variant | ENST00000358273.9 | |||
EVI2A | NM_001003927.3 | c.640G>A | p.Ala214Thr | missense_variant | 3/3 | ||
NF1 | NM_000267.3 | c.4773-7377C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EVI2A | ENST00000462804.3 | c.571G>A | p.Ala191Thr | missense_variant | 2/2 | 1 | NM_014210.4 | P2 | |
NF1 | ENST00000358273.9 | c.4836-7377C>T | intron_variant | 1 | NM_001042492.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000758 AC: 19AN: 250748Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135552
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461686Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727134
GnomAD4 genome AF: 0.000374 AC: 57AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.640G>A (p.A214T) alteration is located in exon 3 (coding exon 2) of the EVI2A gene. This alteration results from a G to A substitution at nucleotide position 640, causing the alanine (A) at amino acid position 214 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at